Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

Autores: Márquez Rodas, I.; Saiag, P.; de la Cruz Merino, L.; Dutriaux, C.; Rodríguez-Moreno, J.; Robert, C.; Arance, A.; Castañón Álvarez, Eduardo; Cerezuela-Fuentes, P.; Montaudie, H.; Fernández de Sanmamed Gutiérrez, Miguel; González Cao, M.; Charles, J.; López Criado, M.; Berrocal, A.; de Miguel, E.; Funk-Brentano, E.; Prey, S.; Huertas, R.; Rodríguez Abreu, D.; Muñoz Couselo, E.; Martín-Liberal, J.; Sánchez López, J.; Escuin-Ordinas, H.; Quintero, M.; Macia, S.; Chaney, M.; Dalle, S.